Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peripheral T-Cell Lymphoma (PTCL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06137144
What this trial is testing

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

Who this might be right for
LymphomaNon-Hodgkin LymphomaHodgkin Lymphoma+4 more
AstraZeneca 161
Early research (Phase 1)Study completedNCT00355472
What this trial is testing

Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL

Who this might be right for
Adult T-Cell Leukemia and Lymphoma (ATL)Adult Peripheral T-Cell Lymphoma (PTCL)
Kyowa Kirin Co., Ltd. 16
Early research (Phase 1)Ended earlyNCT01644253
What this trial is testing

Phase 1b Safety and Efficacy Study of TRU-016

Who this might be right for
Chronic Lymphocytic LeukemiaPeripheral T-cell Lymphoma
Aptevo Therapeutics 87
Testing effectiveness (Phase 2)Ended earlyNCT02499627
What this trial is testing

Bendamustine Plus Brentuximab Vedotin in HL and CD30+ PTCL in First Salvage Setting

Who this might be right for
Lymphatic Diseases
Fondazione Italiana Linfomi - ETS 43
Not applicableLooking for participantsNCT07750886
What this trial is testing

Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)

Who this might be right for
Non-Hodgkin LymphomaT-Cell LymphomaDiffuse Large B-Cell Lymphoma+7 more
Natera, Inc. 200
Early research (Phase 1)Looking for participantsNCT04234048
What this trial is testing

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Who this might be right for
T-cell LymphomaCutaneous/Peripheral T-Cell LymphomaPeripheral T-cell Lymphoma+8 more
SciTech Development, Inc. 46
Testing effectiveness (Phase 2)Ended earlyNCT00972842
What this trial is testing

Lenalidomide, Vorinostat and Dexamethasone in Relapsed Patients With Peripheral T-Cell Non-Hodgkin's Lymphoma (PTCL)

Who this might be right for
Peripheral T-Cell Non-Hodgkin's Lymphoma
Arbeitsgemeinschaft medikamentoese Tumortherapie 20
Testing effectiveness (Phase 2)UnknownNCT04705090
What this trial is testing

YY-20394 in Patients With Relapsed or Refractory Peripheral T/NK Cell Lymphoma

Who this might be right for
PTCL
Shanghai YingLi Pharmaceutical Co. Ltd. 90
Testing effectiveness (Phase 2)Ended earlyNCT03547700
What this trial is testing

Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Lymphoma, T-Cell, Peripheral
University of Michigan Rogel Cancer Center 11
Early research (Phase 1)Study completedNCT01169298
What this trial is testing

A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell Lymphoma

Who this might be right for
Adult T-cell Leukemia-LymphomaPeripheral T-cell Lymphoma
Celgene 13
Testing effectiveness (Phase 2)Ended earlyNCT00274651
What this trial is testing

A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas

Who this might be right for
Cutaneous T-Cell LymphomaPeripheral T-Cell LymphomaNon-Hodgkin's Lymphoma
Valerio Therapeutics 53
Large-scale testing (Phase 3)Looking for participantsNCT07414758
What this trial is testing

Golidocitinib Versus Placebo as Maintenance Therapy in PTCL Patients With Response (CR/PR) After First-Line Chemotherapy

Who this might be right for
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 68
Testing effectiveness (Phase 2)Looking for participantsNCT06421948
What this trial is testing

Linperlisib Combined With Chidamide in Patients With PTCL

Who this might be right for
Peripheral T-cell Lymphoma
Yanyan Liu 134
Not applicableUnknownNCT03672084
What this trial is testing

Allo-HSCT as First-line Consolidation in High-risk PTCL

Who this might be right for
T Cell Lymphoma
Peking University People's Hospital 50
Testing effectiveness (Phase 2)Study completedNCT01716806
What this trial is testing

Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Hodgkin DiseasePeripheral T Cell Lymphoma
Seagen Inc. 131
Testing effectiveness (Phase 2)UnknownNCT00840385
What this trial is testing

Orally Fludarabine, Adriamycin and Dexamethasone (FAD) in Newly Diagnosed Peripheral T-cell Lymphomas (PTCL)

Who this might be right for
T-Cell LymphomasChemotherapy
Fudan University 30
Early research (Phase 1)Ended earlyNCT05403450
What this trial is testing

Tolinapant in Combination With Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma (R/R PTCL)

Who this might be right for
Relapsed/Refractory Peripheral T-cell Lymphoma
Taiho Oncology, Inc. 33
Testing effectiveness (Phase 2)Study completedNCT00888927
What this trial is testing

Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T-Cell Lymphoma
Kyowa Kirin Co., Ltd. 42
Testing effectiveness (Phase 2)Looking for participantsNCT06855823
What this trial is testing

A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCL

Who this might be right for
Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL)
Sun Yat-sen University 33
Early research (Phase 1)Study completedNCT02689453
What this trial is testing

Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL)

Who this might be right for
T-Cell Lymphoma RelapsedAdult T-Cell Leukemia (ATL)Peripheral T-Cell Lymphoma (PTCL)+2 more
National Cancer Institute (NCI) 11
Next Page